Clinical Trials and Precision Oncology
Clinical Trials are research studies designed to answer scientific questions and discover better ways to prevent, diagnose, and treat health conditions like cancer. Research at the University of Illinois Cancer Center is organized into three broad, thematic programs that are mechanism-based and focused on making discoveries that can improve cancer treatment, diagnosis, and prevention. Our Cancer Center includes over 250 researchers and physicians, with cancer-related research funding exceeding $59 million.
We focus on studies we think will be practice-changing while assessing and ensuring that the feasibility and eligibility for the studies selected make sense for our population of patients.
We are highly interested in bringing novel immune checkpoint antibodies, bispecific antibodies, and immunologic engager antibodies to our patients as we recognize the inherent importance of the tumor and host immune landscape in driving cancer initiation, progression, and metastases.
Precision Oncology: The precision oncology program at UIC provides a molecular tumor board (precision oncology tumor board/POTB) that accepts external referrals, creates educational content around rapidly updating targeted treatments, and helps match patients with biomarker-based clinical trials.
Click here for more information about current clinical trials at UI Health.